InspireMD (NSPR) Misses Q2 EPS by 5c

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.26), $0.05 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.78 million versus the consensus estimate of $1.92 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• eToro Group (ETOR) Reiterated at Market Outperform by Citizens as EBITDA Rises 9%
• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Adecoagro S.A. (AGRO) Misses Q2 EPS by 63c